As of May 25, 2025, XpresSpa Group Inc has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.66, this represents a potential upside of -1209.8%.
Key Metrics | Value |
---|---|
DCF Fair Value (5-year) | $0.00 |
DCF Fair Value (10-year) | $0.00 |
Potential Upside (5-year) | -1346.3% |
Potential Upside (10-year) | -1209.8% |
Discount Rate (WACC) | 5.3% - 8.3% |
Revenue is projected to grow from $56 million in 12-2022 to $72 million by 12-2032, representing a compound annual growth rate of approximately 2.5%.
Fiscal Year | Revenue (USD millions) | Growth |
---|---|---|
12-2022 | 56 | 24% |
12-2023 | 56 | 1% |
12-2024 | 57 | 2% |
12-2025 | 60 | 4% |
12-2026 | 61 | 2% |
12-2027 | 64 | 5% |
12-2028 | 65 | 3% |
12-2029 | 67 | 2% |
12-2030 | 68 | 2% |
12-2031 | 70 | 3% |
12-2032 | 72 | 2% |
Net profit margin is expected to improve from -58% in 12-2022 to -37% by 12-2032, driven by operational efficiency and economies of scale.
Fiscal Year | Net Profit (USD millions) | Profit Margin |
---|---|---|
12-2022 | (33) | -58% |
12-2023 | (31) | -54% |
12-2024 | (29) | -50% |
12-2025 | (28) | -47% |
12-2026 | (26) | -44% |
12-2027 | (26) | -40% |
12-2028 | (26) | -40% |
12-2029 | (26) | -39% |
12-2030 | (26) | -39% |
12-2031 | (27) | -38% |
12-2032 | (27) | -37% |
. Projected CapEx is expected to maintain at approximately 6% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
Fiscal Year | D&A (USD millions) |
---|---|
12-2023 | 5 |
12-2024 | 6 |
12-2025 | 6 |
12-2026 | 5 |
12-2027 | 4 |
12-2028 | 4 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
Components | Average Days |
---|---|
Days Receivables | 7 |
Days Inventory | 15 |
Days Payables | 6 |
Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
---|---|---|---|---|---|
2023 | (25) | (0) | 4 | 0 | (29) |
2024 | (23) | (0) | 4 | (0) | (26) |
2025 | (22) | (0) | 4 | 0 | (25) |
2026 | (21) | (0) | 4 | 0 | (25) |
2027 | (22) | (0) | 4 | 0 | (26) |
Valuation Method | Fair Price (USD) | Potential Upside |
---|---|---|
5-Year DCF (Growth) | 0.00 | -1346.3% |
10-Year DCF (Growth) | 0.00 | -1209.8% |
5-Year DCF (EBITDA) | 0.00 | -100.0% |
10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is XpresSpa Group Inc (XSPA) a buy or a sell? XpresSpa Group Inc is definitely a sell. Based on our DCF analysis, XpresSpa Group Inc (XSPA) appears to be overvalued with upside potential of -1209.8%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.66.